Bone Marrow Transplantation - Table of Contents alert Volume 47 Issue 5

TABLE OF CONTENTS Volume 47, Issue 5 (May 2012) In this issue Editorial Reviews Original Articles Letters to the Editor Also new AOP Advertisement The CliniMACS® Cell Separation System, based on MACS® Technology, enables the operator to perform clinical-scale magnetic enrichment of target cells or depletion of unwanted cells. Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Special Feature and Web Focus on Autoimmune Disease Immunology and Cell Biology is proud to present a Special Feature and web focus on Autoimmune Disease which includes a review series featuring articles on clinical translation, and the current state of research in this area. Access the Autoimmune Disease Special Feature and Web Focus today!   Editorial Top A bit of antithymocyte globulin can take you a long way! M Mohty Bone Marrow Transplant 2012 47: 617-618; 10.1038/bmt.2012.6 Full Text Reviews Top Metabolic syndrome and cardiovascular risk in survivors after hematopoietic cell transplantation K S Baker, E Chow and J Steinberger Bone Marrow Transplant 2012 47: 619-625; advance online publication, June 6, 2011; 10.1038/bmt.2011.118 Abstract | Full Text Assessing causal relationships between treatments and clinical outcomes: always read the fine print B Freidlin and E L Korn Bone Marrow Transplant 2012 47: 626-632; advance online publication, May 30, 2011; 10.1038/bmt.2011.119 Abstract | Full Text Original Articles Top CONDITIONING REGIMENS Intravenous compared with oral busulfan as preparation for allogeneic hematopoietic progenitor cell transplantation for AML and MDS R M Sobecks, L Rybicki, M Yurch, M Kalaycio, R Dean, S Andresen, B Pohlman, H Duong, B Bolwell and E Copelan Bone Marrow Transplant 2012 47: 633-638; advance online publication, August 29, 2011; 10.1038/bmt.2011.167 Abstract | Full Text The increase from 2.5 to 5 mg/kg of rabbit anti-thymocyte-globulin dose in reduced intensity conditioning reduces acute and chronic GVHD for patients with myeloid malignancies undergoing allo-SCT R Devillier, R Crocchiolo, L Castagna, S Fürst, J El Cheikh, C Faucher, T Prebet, A Etienne, C Chabannon, N Vey, B Esterni and D Blaise Bone Marrow Transplant 2012 47: 639-645; advance online publication, February 6, 2012; 10.1038/bmt.2012.3 Abstract | Full Text PEDIATRIC TRANSPLANTS Reduced-intensity conditioning hematopoietic SCT for pediatric patients with LAD-1: clinical efficacy and importance of chimerism A A Hamidieh, Z Pourpak, M Hosseinzadeh, M R Fazlollahi, K Alimoghaddam, M Movahedi, A Hosseini, Z Chavoshzadeh, M Jalili, S Arshi, M Moin and A Ghavamzadeh Bone Marrow Transplant 2012 47: 646-650; advance online publication, July 11, 2011; 10.1038/bmt.2011.140 Abstract | Full Text Evaluation of oxidative and antioxidative parameters in pediatric hematopoietic SCT patients S Sabuncuoğlu, B Kuşkonmaz, D Uckun Çetinkaya and H Özgüneş Bone Marrow Transplant 2012 47: 651-656; advance online publication, July 18, 2011; 10.1038/bmt.2011.145 Abstract | Full Text Decreased bone mineral density in young adults treated with SCT in childhood: the role of 25-hydroxyvitamin D P Frisk, J Arvidson, Ö Ljunggren and J Gustafsson Bone Marrow Transplant 2012 47: 657-662; advance online publication, July 18, 2011; 10.1038/bmt.2011.147 Abstract | Full Text Feasibility and outcome of haploidentical SCT in pediatric high-risk hematologic malignancies and Fanconi anemia in Uruguay G Dufort, S Pisano, A Incoronato, M Castiglioni, M Carracedo, C Pagés, E Simon, S Zuccolo, R Barcelona, R Mezzano, A Tiscornia, F Lemos, F Morosini, M Schelotto, H Giordano, E Carreto, M Bengoechea, B Boggia, I Rodriguez, L Guerrero, A Dabezies and L Castillo Bone Marrow Transplant 2012 47: 663-668; advance online publication, July 18, 2011; 10.1038/bmt.2011.148 Abstract | Full Text ALLOGRAFTING Incidence of extramedullary relapse after haploidentical SCT for advanced AML/myelodysplastic syndrome S Yoshihara, K Ikegame, K Kaida, K Taniguchi, R Kato, T Inoue, T Fujioka, H Tamaki, M Okada, T Soma and H Ogawa Bone Marrow Transplant 2012 47: 669-676; advance online publication, August 22, 2011; 10.1038/bmt.2011.163 Abstract | Full Text Access to allogeneic hematopoietic SCT for patients with MDS or relapsed AML treated according to protocols of the Dutch Childhood Oncology Group M M Jöris, M B Bierings, R M Egeler, F H J Claas, J J van Rood and M Oudshoorn Bone Marrow Transplant 2012 47: 677-683; advance online publication, August 22, 2011; 10.1038/bmt.2011.168 Abstract | Full Text POST-TRANSPLANT EVENTS Growth hormone treatment impact on growth rate and final height of patients who received HSCT with TBI or/and cranial irradiation in childhood: a report from the French Leukaemia Long-Term Follow-Up Study (LEA) F Isfan, J Kanold, E Merlin, A Contet, N Sirvent, E Rochette, M Poiree, D Terral, H Carla-Malpuech, R Reynaud, B Pereira, P Chastagner, M C Simeoni, P Auquier, G Michel and F Deméocq Bone Marrow Transplant 2012 47: 684-693; advance online publication, July 4, 2011; 10.1038/bmt.2011.139 Abstract | Full Text Serial intestinal endoscopic examinations of patients with persistent diarrhea after allo-SCT C Martínez, M Rosales, X Calvo, M Cuatrecasas, L Rodriguez-Carunchio, J Llach, F Fernández-Avilés, L Rosiñol, M Rovira, E Carreras and Á Urbano-Ispízua Bone Marrow Transplant 2012 47: 694-699; advance online publication, July 11, 2011; 10.1038/bmt.2011.143 Abstract | Full Text Outcomes of a 1-day nonmyeloablative salvage regimen for patients with primary graft failure after allogeneic hematopoietic cell transplantation J Kanda, M E Horwitz, G D Long, C Gasparetto, K M Sullivan, J P Chute, A Morris, T Hennig, Z Li, N J Chao and D A Rizzieri Bone Marrow Transplant 2012 47: 700-705; advance online publication, August 1, 2011; 10.1038/bmt.2011.158 Abstract | Full Text Increased costs after allogeneic haematopoietic SCT are associated with major complications and re-transplantation B-M Svahn, M Remberger, O Alvin, H Karlsson and O Ringdén Bone Marrow Transplant 2012 47: 706-715; advance online publication, August 29, 2011; 10.1038/bmt.2011.162 Abstract | Full Text The impact of hematopoietic stem cell transplantation on sexuality: a systematic review of the literature K H Thygesen, I Schjødt and M Jarden Bone Marrow Transplant 2012 47: 716-724; advance online publication, August 29, 2011; 10.1038/bmt.2011.169 Abstract | Full Text The effect of oral management on the severity of oral mucositis during hematopoietic SCT K Yamagata, C Arai, H Sasaki, Y Takeuchi, K Onizawa, T Yanagawa, N Ishibashi, R Karube, K Shinozuka, Y Hasegawa, S Chiba and H Bukawa Bone Marrow Transplant 2012 47: 725-730; advance online publication, August 29, 2011; 10.1038/bmt.2011.171 Abstract | Full Text GRAFT-VERSUS-HOST DISEASE Immunohistochemistry of affected tissue may guide cGVHD treatment decisions K M Williams, L W Ostrow, D M Loeb, T Chung, R D Cohn, A M Corse, A L Mammen and A R Chen Bone Marrow Transplant 2012 47: 731-733; advance online publication, September 19, 2011; 10.1038/bmt.2011.164 Abstract | Full Text Letters to the Editor Top Disseminated Geosmithia argillacea infection in a patient with gastrointestinal GvHD T Valentin, P Neumeister, M Pichler, A Rohn, C Koidl, D Haas, B Heiling, M Asslaber, I Zollner-Schwetz, M Hoenigl, H J F Salzer, R Krause and W Buzina Bone Marrow Transplant 2012 47: 734-736; advance online publication, July 25, 2011; 10.1038/bmt.2011.149 Full Text Lack of efficacy of rituximab in refractory sclerodermatous chronic GVHD L George, B George, D J Gottlieb, M Hertzberg and P Fernandez-Peñas Bone Marrow Transplant 2012 47: 737-738; advance online publication, July 25, 2011; 10.1038/bmt.2011.150 Full Text Oral cryotherapy can significantly reduce oral mucositis but not acute GVHD incidence in Flu/Mel conditioning allo-SCT S Vokurka, T Svoboda, A Jungova, M Karas and V Koza Bone Marrow Transplant 2012 47: 739-741; advance online publication, July 25, 2011; 10.1038/bmt.2011.156 Full Text Non-myeloablative allogenic BMT for myelodysplastic syndrome successfully controlled accompanying relapsing polychondritis J Tomomatsu, Y Hamano, J Ando, N Komatsu and K Sugimoto Bone Marrow Transplant 2012 47: 742-743; advance online publication, August 8, 2011; 10.1038/bmt.2011.159 Full Text T-cell-depleted hematopoietic SCT from unrelated donors for the treatment of congenital amegakaryocytic thrombocytopenia N Tarek, N A Kernan, S E Prockop, A Scaradavou, T N Small, R J O'Reilly and F Boulad Bone Marrow Transplant 2012 47: 744-746; advance online publication, July 25, 2011; 10.1038/bmt.2011.142 Full Text Ustekinumab demonstrates activity in glucocorticoid-refractory acute GVHD J Pidala, L Perez, F Beato and C Anasetti Bone Marrow Transplant 2012 47: 747-748; advance online publication, August 29, 2011; 10.1038/bmt.2011.172 Full Text Advertisement The Arab world has a rich history of scientific breakthroughs. Ensure you're part of the scientific and medical community gaining access to breaking news in the region. Access Nature Middle East - your free portal for scientific and medical research, features, jobs and events in the Arabic speaking world. www.nature.com/nmiddleeast/ Follow us: Facebook, Twitter, & Google +   Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Bone Marrow Transplantation. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2012 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.